These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of neutral endopeptidase in dogs with evolving congestive heart failure. Margulies KB; Barclay PL; Burnett JC Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362 [TBL] [Abstract][Full Text] [Related]
4. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure. Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113 [TBL] [Abstract][Full Text] [Related]
5. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure. Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats. Kalinowski L; Szczepanska-Konkel M; Pawelczyk T; Bizon D; Angielski S Ren Physiol Biochem; 1995; 18(5):254-66. PubMed ID: 8869083 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. Margulies KB; Perrella MA; McKinley LJ; Burnett JC J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047 [TBL] [Abstract][Full Text] [Related]
11. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648 [TBL] [Abstract][Full Text] [Related]
12. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Wada A; Tsutamoto T; Matsuda Y; Kinoshita M Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118 [TBL] [Abstract][Full Text] [Related]
13. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure. Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958 [TBL] [Abstract][Full Text] [Related]
15. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure. Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044 [TBL] [Abstract][Full Text] [Related]
16. Studies on potential involvement of protein kinase C in glomerular insensitivity to atrial natriuretic factor on low sodium intake. Kalinowski L; SzczepaĆska-Konkel M; Jankowski M; Angielski S Med Sci Monit; 2001; 7(4):628-34. PubMed ID: 11433187 [TBL] [Abstract][Full Text] [Related]
17. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure. Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099 [TBL] [Abstract][Full Text] [Related]